Authors
Philip Sambrook, Joan Birmingham, Paul Kelly, Susan Kempler, Tuan Nguyen, Nicholas Pocock, John Eisman
Publication date
1993/6/17
Journal
New England Journal of Medicine
Volume
328
Issue
24
Pages
1747-1752
Publisher
Massachusetts Medical Society
Description
Background
Prolonged corticosteroid therapy increases the risk of osteoporosis and fracture. We studied whether corticosteroid-induced osteoporosis could be prevented by treatment with calcium, calcitriol (1,25-dihydroxyvitamin D3), and calcitonin.
Methods
One hundred three patients starting long-term corticosteroid therapy were randomly assigned to receive 1000 mg of calcium per day orally and either calcitriol (0.5 to 1.0 μg per day orally) plus salmon calcitonin (400 IU per day intranasally), calcitriol plus a placebo nasal spray, or double placebo for one year. Data on treatment efficacy were available for 92 of these patients. Bone density was measured every four months for two years by photon absorptiometry. There were no significant differences between groups with respect to age, underlying disease, initial bone density, or corticosteroid dose during the first year.
Results
Calcitriol (mean dose, 0.6 μg per …
Total citations
19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024426213035454159473852413022201761411131191071273511231
Scholar articles
P Sambrook, J Birmingham, P Kelly, S Kempler… - New England Journal of Medicine, 1993